Latest United Kingdom Startup Funding Rounds
Startup funding in United Kingdom: recent rounds, the companies behind them and their participating investors.
- Rounds
- 652 All time
- Disclosed funding
- $38.4B 521 disclosed amounts
- Median round
- $7.7M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| V ViridiCompany profile Viridi develops catalysts that help chemical manufacturers use captured carbon dioxide and improve production processes. Viridi develops catalysts that help chemical manufacturers use captured carbon dioxide and improve production processes. | £3M | Seed | Climate tech | United Kingdom | Investors | |
| AT Alchemab TherapeuticsCompany profile Alchemab Therapeutics develops antibody medicines by studying people resilient to disease. Alchemab Therapeutics develops antibody medicines by studying people resilient to disease. | £1.7M | Biomedical Catalyst grantUndisclosed | Biotech | United Kingdom | Investors | |
MetaviewCompany profile Metaview provides AI agents and software for recruiters and hiring teams, from candidate sourcing and screening to interview notes and reporting. Metaview provides AI agents and software for recruiters and hiring teams, from candidate sourcing and screening to interview notes and reporting. | $6M | Seed | AI | United Kingdom | Investors | |
Cognitive CreditCompany profile Cognitive Credit provides corporate credit data, financial models and AI analysis tools for investment banks and asset managers. Cognitive Credit provides corporate credit data, financial models and AI analysis tools for investment banks and asset managers. | £6M | Series A | Fintech | United Kingdom | Investors | |
| F FabricNanoCompany profile FabricNano develops enzyme engineering technology for industrial biomanufacturing. FabricNano develops enzyme engineering technology for industrial biomanufacturing. | $12.5M | Series A | Biotech | United Kingdom | Investors | |
| AT Alchemab TherapeuticsCompany profile Alchemab Therapeutics develops antibody medicines by studying people resilient to disease. Alchemab Therapeutics develops antibody medicines by studying people resilient to disease. | £60M | Series A | Biotech | United Kingdom | Investors | |
| AT Alchemab TherapeuticsCompany profile Alchemab Therapeutics develops antibody medicines by studying people resilient to disease. Alchemab Therapeutics develops antibody medicines by studying people resilient to disease. | Undisclosed | Biomedical Catalyst grantUndisclosed | Biotech | United Kingdom | Investors | |
| EE Edge EsportsCompany profile Contract and payment software for esports teams, tournament organisers and influencer campaigns. Contract and payment software for esports teams, tournament organisers and influencer campaigns. | $1.5M | Undisclosed | Fintech | United Kingdom | Investors | |
| GE Guild EsportsCompany profile Guild Esports built a British competitive gaming organisation around professional teams, player development and commercial partnerships. Guild Esports built a British competitive gaming organisation around professional teams, player development and commercial partnerships. | £245.7K | Beckham strategic investmentUndisclosed | Media & gaming | United Kingdom | Investors | |
| UQ Universal QuantumCompany profile Modular trapped-ion quantum computers built by connecting small quantum chips. Modular trapped-ion quantum computers built by connecting small quantum chips. | £3.6M | Seed | Hardware | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Innovate UK
FluoRok, Octopath AI, Emerald
48rounds0led - 2Bethnal Green Ventures
Novi Innovations, Cerebella, Soil Systems
37rounds0led - 3British Business Bank
Fractile, Microbiotica, OMass Therapeutics
20rounds2led - 4Balderton Capital
Fractile, Sava Technologies, Unit1 Studio
16rounds5led - 5NVIDIA
Riverlane, Foresight, Hiverge
15rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.